StemSight
Seed Round in 2025
StemSight is a Tampere, Finland-based cell therapy startup focused on developing innovative treatments for blindness. The company has created an off-the-shelf cell therapy platform that utilizes induced pluripotent stem cells (iPSCs) and biomaterials. Its initial target is to provide a first-in-class therapy for limbal stem cell deficiency, a rare condition leading to corneal blindness. StemSight aims to expand its offerings over time to address more common forms of corneal blindness, ultimately enabling patients suffering from these conditions to regain their vision.
Gesynta Pharma
Series B in 2025
Gesynta Pharma AB is a clinical-stage pharmaceutical company based in Stockholm, Sweden, founded in 2017. The company focuses on developing compounds that inhibit the pro-inflammatory enzyme microsomal prostaglandin E synthase-1 (mPGES-1) to address chronic inflammatory conditions, particularly in cardiovascular diseases and cancer. Its most advanced drug candidate, vipoglanstat (GS-248), is being developed as a non-hormonal treatment for endometriosis, a painful condition affecting around 10 percent of women of reproductive age. Clinical studies have indicated that vipoglanstat significantly reduces endometriotic lesions and provides pain relief, with preparations underway for a phase II clinical trial. Additionally, Gesynta Pharma is advancing another candidate, GS-073, which is set to enter phase I clinical trials for a different inflammatory condition. The company's research is rooted in work from the Karolinska Institutet, and it aims to deliver safe and effective treatments for serious diseases.
Hycamite TCD Technologies is a privately-owned company focused on the commercialization of advanced environmental technology derived from research conducted at several European universities. The company specializes in producing clean hydrogen by processing methane without emitting carbon dioxide. Its innovative technology separates methane into hydrogen and solid high-quality carbon, enabling the generation of clean hydrogen and pure carbon. This process effectively decomposes methane from natural gas or biogas into its elemental components, serving as both an industrial raw material and a fuel source. Through its sustainable approach, Hycamite aims to contribute to the reduction of greenhouse gas emissions and promote cleaner energy solutions.
Fiberwood
Series A in 2024
Fiberwood is a manufacturer of eco-friendly wood fiber insulation boards, specializing in sustainable and ecological solutions for construction and packaging. Leveraging foam-forming technology, Fiberwood produces circular, fossil-free insulation and packaging materials using forestry by-products and natural fibers. The company's products serve as environmentally friendly, recyclable alternatives to traditional mineral wool insulation and cellular plastic packaging, promoting resource efficiency and sustainability. With excellent insulating properties and a commitment to eliminating plastic and fossil-based materials, Fiberwood strives to support sustainable building practices and reduce the environmental impact of packaging solutions.
NPHarvest
Seed Round in 2024
NPHarvest specializes in transforming organic waste and wastewater into valuable fertilizer, thereby reducing environmental impact. The company employs energy-efficient membrane stripping and lime-based phosphorus recovery techniques to recycle nitrogen and phosphorus, creating a cost-effective and sustainable nutrient source for agriculture.
Ninyes
Pre Seed Round in 2023
Ninyes is a company that transforms the secondhand market into a profitable venture for fashion brands through its innovative Resale-as-a-Service solution. Recognizing the rapid growth of the secondhand market, Ninyes provides a professional B2B platform that moves resale from a cumbersome peer-to-peer model to a streamlined business operation. The company specializes in managing the resale of second-hand clothing and accessories, offering comprehensive services that include logistics, warehousing, selling, marketing, and data analytics. By optimizing the resale business for sustainable fashion brands, Ninyes enables these companies to benefit from multiple sales channels and markets, enhancing their profitability while promoting sustainability in the fashion industry.
Hycamite
Venture Round in 2023
Hycamite TCD Technologies is a privately-owned company focused on the commercialization of advanced environmental technology derived from research conducted at several European universities. The company specializes in producing clean hydrogen by processing methane without emitting carbon dioxide. Its innovative technology separates methane into hydrogen and solid high-quality carbon, enabling the generation of clean hydrogen and pure carbon. This process effectively decomposes methane from natural gas or biogas into its elemental components, serving as both an industrial raw material and a fuel source. Through its sustainable approach, Hycamite aims to contribute to the reduction of greenhouse gas emissions and promote cleaner energy solutions.
TILT Biotherapeutics
Venture Round in 2023
TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, specializing in the development of genetically modified oncolytic viruses to enhance T-cell therapies for cancer treatment. Established in 2013, the company focuses on utilizing its patented technology to improve tumor-infiltrating lymphocyte (TIL) and chimeric antigen receptor (CAR-T) therapies, as well as checkpoint inhibiting antibody treatments. TILT Biotherapeutics is advancing products such as TILT-123, TILT-234, and TILT-321, which aim to modify the tumor microenvironment and boost immune responses against cancer. The company's innovative approach holds promise for achieving effective results in treating solid tumors, paralleling the successes seen in hematological tumors.
Fiberwood
Seed Round in 2023
Fiberwood is a manufacturer of eco-friendly wood fiber insulation boards, specializing in sustainable and ecological solutions for construction and packaging. Leveraging foam-forming technology, Fiberwood produces circular, fossil-free insulation and packaging materials using forestry by-products and natural fibers. The company's products serve as environmentally friendly, recyclable alternatives to traditional mineral wool insulation and cellular plastic packaging, promoting resource efficiency and sustainability. With excellent insulating properties and a commitment to eliminating plastic and fossil-based materials, Fiberwood strives to support sustainable building practices and reduce the environmental impact of packaging solutions.
TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, specializing in the development of genetically modified oncolytic viruses to enhance T-cell therapies for cancer treatment. Established in 2013, the company focuses on utilizing its patented technology to improve tumor-infiltrating lymphocyte (TIL) and chimeric antigen receptor (CAR-T) therapies, as well as checkpoint inhibiting antibody treatments. TILT Biotherapeutics is advancing products such as TILT-123, TILT-234, and TILT-321, which aim to modify the tumor microenvironment and boost immune responses against cancer. The company's innovative approach holds promise for achieving effective results in treating solid tumors, paralleling the successes seen in hematological tumors.